Diabetes is a chronic condition with devastating complications, mostly due to accelerated micro vascular and macro vascular disorders. Studies have demonstrated that tight control of blood glucose levels minimizes the complications of diabetes. Drugs play an important role in in the treatment of diabetic complications. A rapidly expanding therapeutic armamentarium is now available to treat diabetic complications. More therapeutic options translate into more complex decision making the prescriber. The present study was therefore undertaken to overview the current trends in the analysis of drugs in the treatment of diabetic complications at Basaveshwara teaching and general hospital (BTGH), Gulbarga. A nine month prospective observational study was carried out in the Department of Medicine at Basaveshwara teaching and general hospital (BTGH), Gulbarga. The data was collected from the case sheets and OPD cards of all diabetic complications patients. Out of 145 patients, 93(64.2%) patients were males and 52(35.8%) patients were females. It is observed that diabetic complications are more common in patients of age group 50-59 years (36.6%). Majority of patients 87 (60.1%) had diabetic nephropathy. Pharmacotherapy revealed that, monotherapy was the preferred approach for the treatment of the patients. Diuretic was the drug of choice in monotherapy while Furosemide and Gabapentin was the preferred drugs used in treatment. The overall usage of diuretic (furosemide) during the study period was in 60.1% of the patients. The use of anticonvulsant was found to be in 55.8% of the patients of which, Gabapentin was prescribed for maximum number of patients in 48.3%. The use drugs like AR-β were found to be less. Other agents like Selective Serotonin reuptake inbhitors and antiarrythmics did not find place for the management of diabetic complications even in a single patient during the study period.
